ConductScience.org, home
seasonal allergic rhinitis
API referenceFor AI assistants

Disease · MONDO_0005324

Comparisons in its trials31

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

1 to 20 of 31

Download this page as JSON
ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Fluticasone Propionate Nasal Spray vs Placebo Nasal Spray: serious adverse events0 of 3140 of 312626NCT01817790Trial comparisons
Levocetirizine vs Placebo: serious adverse events1 of 2850 of 293578NCT00653224Trial comparisons
Astepro 0.15% vs Placebo: serious adverse events0 of 2660 of 266532NCT00660829Trial comparisons
Astepro 0.15% vs Placebo: serious adverse events0 of 2510 of 255506NCT00824473Trial comparisons
Astepro 0.15% vs Placebo: serious adverse events0 of 2380 of 242480NCT00719862Trial comparisons
Desloratadine vs Placebo: Number of Participants Who Discontinue Study Drug Due to an AE2 of 2232 of 225448NCT02320396Trial comparisons
Desloratadine vs Placebo: Number of Participants Who Experience at Least One Adverse Event (AE)19 of 22313 of 225448NCT02320396Trial comparisons
Desloratadine vs Placebo: serious adverse events1 of 2230 of 225448NCT02320396Trial comparisons
GSP 301 NS vs Placebo NS: deaths from any cause0 of 2250 of 221446NCT03463031Trial comparisons
GSP 301 NS vs Placebo NS: serious adverse events0 of 2251 of 221446NCT03463031Trial comparisons
Montelukast vs Placebo: serious adverse events0 of 2160 of 218434NCT01857063Trial comparisons
Mometasone Furoate Nasal Spray (MFNS) vs Placebo: serious adverse events0 of 2200 of 209429NCT00468312Trial comparisons
Mometasone Furoate Nasal Spray (MFNS) vs Placebo: serious adverse events0 of 2110 of 215426NCT00453063Trial comparisons
Montelukast 4 mg and 5 mg vs Placebo: serious adverse events1 of 2800 of 133413NCT00968149Trial comparisons
Mometasone Furoate Nasal Spray vs Placebo Nasal Spray.: serious adverse events1 of 2670 of 134401NCT00358527Trial comparisons
Mometasone Furoate Nasal Spray vs Placebo Nasal Spray: serious adverse events0 of 1760 of 175351NCT00732381Trial comparisons
R5713-5714-5715 900 mg vs Placebo: deaths from any cause0 of 1730 of 176349NCT04709575Trial comparisons
R5713-5714-5715 900 mg vs Placebo: serious adverse events3 of 1730 of 176349NCT04709575Trial comparisons
Dymista vs Dymista Vehicle: serious adverse events0 of 1730 of 175348NCT01915823Trial comparisons
BDP HFA 320 µg/Day vs Placebo: serious adverse events1 of 1670 of 171338NCT01024608Trial comparisons

diseases-2026-09-18-0.1.0

Next page

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0005324/comparisons

API referenceFor AI assistants